| __timestamp | Celldex Therapeutics, Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 11606000000 |
| Thursday, January 1, 2015 | 33837000 | 10313000000 |
| Friday, January 1, 2016 | 35979000 | 9762000000 |
| Sunday, January 1, 2017 | 25003000 | 9830000000 |
| Monday, January 1, 2018 | 19269000 | 10102000000 |
| Tuesday, January 1, 2019 | 15426000 | 10615000000 |
| Wednesday, January 1, 2020 | 14456000 | 8955000000 |
| Friday, January 1, 2021 | 20488000 | 9634000000 |
| Saturday, January 1, 2022 | 27195000 | 10042000000 |
| Sunday, January 1, 2023 | 30914000 | 10504000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, operational efficiency is key to maintaining a competitive edge. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: Merck & Co., Inc. and Celldex Therapeutics, Inc., from 2014 to 2023.
Merck, a global leader, consistently reported SG&A expenses averaging around $10 billion annually, reflecting its expansive operations and market reach. In contrast, Celldex, a smaller biotech firm, averaged approximately $24 million, highlighting its focused niche strategy. Notably, Merck's expenses peaked in 2014, while Celldex saw a significant rise in 2015, with a 64% increase from the previous year.
This decade-long comparison underscores the scale and strategic differences between a pharmaceutical giant and a specialized biotech firm, offering insights into their operational priorities and market positioning.
Operational Costs Compared: SG&A Analysis of Eli Lilly and Company and Merck & Co., Inc.
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Novartis AG
Comparing SG&A Expenses: Merck & Co., Inc. vs Merus N.V. Trends and Insights
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Geron Corporation
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Merck & Co., Inc. vs Evotec SE Trends and Insights
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Celldex Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Bausch Health Companies Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Travere Therapeutics, Inc. and Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. or Evotec SE: Who Manages SG&A Costs Better?